Mast cells (MCs) are major effector cells in IgE antibody-dependent allergic disorders, such as anaphylaxis, allergic rhinitis and atopic asthma, which account for a very large burden of illness and economic costs in the developed world. MCsare also critical for the optimal expression of certain innate immune responses. While much attention has been focused on the elements which positively regulate the IgE- and specific antigen (Ag)-dependent secretion of pro-inflammatory mediators and cytokines from MCs, the molecular mechanisms which can suppress the magnitude and/or duration of such responses have been less studied. We recently reported that RabGEFI (Rajb guanine nucleotide exchange factor 1.) can negatively regulate Ras-dependent signaling pathways, and the secretion of all three classes of mediators (pre-formed, lipid and cytokine), in MCs stimulated with IgE and specific Ag. More recently, we found that RabGEFI also importantly regulates responses in MCs which are elicited by the major survival, developmental and proliferation factor for MCs, SCF (stem cell factor, the c-Kit ligand). Notably, our Rabgefl^'mice exhibit severe inflammation of the skin associated with increased numbers of MCs, evidence of dermal MC degranulation (i.e., """"""""activation""""""""), and increased levels of histamine and IgE in the serum. The central questions which we now wish to address are: By what molecular mechanisms does RabGEFI influence MC development, activation and function, and to what extent might these actions of RabGEFI on MCs account for some of the dramatic phenotypic abnormalities observed in Rabgefl^'mice? In Aim 1. we will investigate how RabGEFI, and its individual functional domains, can negatively regulate mouse MC activation induced by signaling via FceRI or c-Kit (the SCF receptor) in vitro or in vivo, and will identify and characterize RabGEFI-interacting proteins and their downstream effectors in MCswhich have been activated via these receptors.
In Aim 2. we will define the mechanisms by which RabGEFI can regulate the survival, development, phenotype &proliferation of MCs in vitro and in vivo. The in vivo studies will take advantage of our ability to transfer in wfro-derived MCs which lack, or express mutant forms of, RabGEFI into the tissues of c-kit mutant, Kitw/w~v or Kit""""""""-3?""""""""'*"""""""" genetically MC-deficient mice (which express wild type RabGEFI). We thus can study the effects of RabGEFI on MCs in mice in which only the MCs lack, or express mutant forms of, RabGEFI. Elucidating how RabGEFI negatively regulates FceRI- or c-Kit-dependent signaling in MCs will increase our understanding of the regulation of MC activation and development, which is the long-term goal of this project. Such work also may help in the development of new therapeutic approaches for the alleviation of diseases, such as asthma and atopic dermatitis, which are associated with IgE-dependent MC activation and, in many patients, with increased numbers of MCs in the affected tissues.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI023990-23
Application #
7565937
Study Section
Cellular and Molecular Immunology - B (CMI)
Program Officer
Plaut, Marshall
Project Start
1986-09-01
Project End
2011-01-31
Budget Start
2009-02-01
Budget End
2010-01-31
Support Year
23
Fiscal Year
2009
Total Cost
$411,257
Indirect Cost
Name
Stanford University
Department
Pathology
Type
Schools of Medicine
DUNS #
009214214
City
Stanford
State
CA
Country
United States
Zip Code
94305
Tam, Issan Yee San; Ng, Chun Wai; Tam, See-Ying et al. (2017) Novel six-week protocol for generating functional human connective tissue-type (MCTC) mast cells from buffy coats. Inflamm Res 66:25-37
Mukai, Kaori; Karasuyama, Hajime; Kabashima, Kenji et al. (2017) Differences in the Importance of Mast Cells, Basophils, IgE, and IgG versus That of CD4+ T Cells and ILC2 Cells in Primary and Secondary Immunity to Strongyloides venezuelensis. Infect Immun 85:
Reber, Laurent L; Gillis, Caitlin M; Starkl, Philipp et al. (2017) Neutrophil myeloperoxidase diminishes the toxic effects and mortality induced by lipopolysaccharide. J Exp Med 214:1249-1258
Balbino, Bianca; Sibilano, Riccardo; Starkl, Philipp et al. (2017) Pathways of immediate hypothermia and leukocyte infiltration in an adjuvant-free mouse model of anaphylaxis. J Allergy Clin Immunol 139:584-596.e10
Reber, Laurent L; Sibilano, Riccardo; Starkl, Philipp et al. (2017) Imaging protective mast cells in living mice during severe contact hypersensitivity. JCI Insight 2:
Gaudenzio, Nicolas; Sibilano, Riccardo; Marichal, Thomas et al. (2016) Different activation signals induce distinct mast cell degranulation strategies. J Clin Invest 126:3981-3998
Murakami, Jodi L; Xu, Baohui; Franco, Christopher B et al. (2016) Evidence that ?7 Integrin Regulates Hematopoietic Stem Cell Homing and Engraftment Through Interaction with MAdCAM-1. Stem Cells Dev 25:18-26
Starkl, Philipp; Marichal, Thomas; Gaudenzio, Nicolas et al. (2016) IgE antibodies, Fc?RI?, and IgE-mediated local anaphylaxis can limit snake venom toxicity. J Allergy Clin Immunol 137:246-257.e11
Marichal, Thomas; Gaudenzio, Nicolas; El Abbas, Sophie et al. (2016) Guanine nucleotide exchange factor RABGEF1 regulates keratinocyte-intrinsic signaling to maintain skin homeostasis. J Clin Invest 126:4497-4515
Morita, Hideaki; Arae, Ken; Unno, Hirotoshi et al. (2015) An Interleukin-33-Mast Cell-Interleukin-2 Axis Suppresses Papain-Induced Allergic Inflammation by Promoting Regulatory T Cell Numbers. Immunity 43:175-86

Showing the most recent 10 out of 170 publications